Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Ultragenyx Pharmaceutical, Inc.
(RARE)
NASDAQ
:RARE
RARE
Ultragenyx Pharmaceutical
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
Drug Pipeline
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Ultragenyx Pharmaceutical (RARE) Stock News & Sentiment
AI Analyst Report
Follow
1,217
Followers
Premium
Company Announcements
Ultragenyx BLA for UX111 Accepted for FDA Review
12d ago
8K
RARE
Premium
Company Announcements
Ultragenyx Wins FDA IND Clearance for UX016 Therapy
15d ago
8K
RARE
Premium
Company Announcements
Ultragenyx Nears Key Inflection Point With Completed Phase 3 Gene Therapy Study in GSDIa
20d ago
RARE
Premium
Market News
Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims
21d ago
NVS
MREO
Premium
Market News
Ultragenyx Facing Shareholder Lawsuit over Brittle Bone Disease Drug Claims
27d ago
RARE
Premium
Company Announcements
Ultragenyx Announces Positive Phase 3 Results for DTX301
1M ago
8K
RARE
Premium
Class Action
Ultragenyx Pharmaceutical Faces Investor Lawsuit Following Study Failures and Stock Decline
2M ago
RARE
More RARE News >
RARE News on the Web
All News
Bearish News
Bullish News
2026-04-13
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
TipRanks News
Neutral
2026-04-09
CNBC Cures: A father and a doctor on how raising a child with Angelman syndrome changed him
CNBC
Neutral
2026-04-09
RBC Capital Reaffirms Their Buy Rating on Ultragenyx Pharmaceutical (RARE)
TipRanks News
Bullish
2026-04-08
Ultragenyx Stock Tumbles After Discounted Share Offering
TipRanks News
Bearish
2026-04-08
Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Lags Revenue Estimates
Zacks
Neutral
2026-04-06
RARE Rises as FDA Accepts Resubmitted BLA for Sanfilippo Syndrome
Zacks
Bearish
2026-04-03
Ultragenyx Insider Move: CFO’s Stock Sale Sparks Fresh Investor Buzz
TipRanks News
Neutral
2026-04-03
Insider Sell: Howard Horn Sells Shares of Ultragenyx Pharmaceutical Inc (RARE)
GuruFocus News
Neutral
146
Results | Showing
1
out of
19
News Score - Last 7 Days
Neutral
RARE
Sector Average
Media Buzz
This Week
5 articles
Weekly Average
6 articles
News Sentiment
This Week
39%
Sector Average
68%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines
Media Buzz
and
News Sentiment
.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is RARE’s Media Buzz Sentiment?
5 articles about RARE were published this week. In an average week, 6 articles are published.
What is RARE’s weekly average amount of articles?
In an average week, 6 articles about RARE are published.
What is RARE’s News Sentiment?
39% of articles about RARE were positive this week, compared to its sector average of 68%.
Healthcare Stocks that are Trending in the News
TXTM
ProText Mobility
STAA
Staar Surgical
ALLO
Allogene Therapeutics
REPL
Replimune Group
IVVD
Invivyd
Showing the stocks with the most bullish news sentiment over the past week
See the stocks with the most bullish news sentiment in the sector
Upgrade Now
You need to enable JavaScript to run this app.